e-learning
resources
Amsterdam 2015
Wednesday, 30.09.2015
Cellular and molecular mechanisms of COPD and emphysema
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
In search of ckit+ stem cells in lung tissue
Alejandra Lopez Giraldo (Barcelona, Spain), Alejandra López-Giraldo, Tamara Cruz, Rosa Faner, Alvar Agustí
Source:
International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Session:
Cellular and molecular mechanisms of COPD and emphysema
Session type:
Poster Discussion
Number:
5062
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Alejandra Lopez Giraldo (Barcelona, Spain), Alejandra López-Giraldo, Tamara Cruz, Rosa Faner, Alvar Agustí. In search of ckit+ stem cells in lung tissue. Eur Respir J 2015; 46: Suppl. 59, 5062
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
iPSC derived lung stem cells as tools to understand lung regeneration and disease
Source: ERS Lung Science Conference 2021
Year: 2021
Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 190-204
Year: 2021
Impaired migration of bone marrow mesenchymal stem cells in COPD
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 205-221
Year: 2021
IPF lung resident mesenchymal stem cells differentiate into epithelial cells displaying a disease-specific transcriptome
Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2019
Immunotherapeutic strategy with mesenchymal stem cells modulating inflammation in an experimental model of COPD.
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020
Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury
Source: Eur Respir J 2009; 34: 740
Year: 2009
Identification and characterization of mesenchymal stem cells in the human lung
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
The therapeutic potential of the mesenchymal stem cell secretome in a mouse model of chronic inflammatory lung disease
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
Modelling human lung development and disease using pluripotent stem cells
Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats
Year: 2015
Characterization of human mesenchymal stem cells phenotype and secretome in a in vitro model of acute lung injury inflammation
Source: Annual Congress 2011 - Lung cell injury and repair
Year: 2011
Human mesenchymal stem cell exosomes attenuate inflammation of lung epithelial cells through miR-223 in acute lung injury
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
3D models of human lung development and disease using pluripotent stem cells
Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung
Year: 2019
Using induced pluripotent stem cells to model the human lung alveolar epithelium
Source: International Congress 2018 – Pathophysiology of the human lung alveolus
Year: 2018
LSC - 2020 - Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis patients
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Fibrosis-specific stem-like cells in peripheral IPF lung: Characteristics and potential role
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020
The role of resident lung mesenchymal stromal cells in normal and aberrant lung development
Source: Virtual Congress 2020 – Cellular involvement in lung injury
Year: 2020
YI04 - Recruitment of stem cell populations to the lung with disease
Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration
Year: 2012
Intersections of lung progenitor cells, lung disease and lung cancer
Source: Eur Respir Rev, 26 (144) 170054; 10.1183/16000617.0054-2017
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept